Alembic Pharmaceuticals Q2 Results: Shares jump 20% after profit rises 81%; US business grows 77%

In the international business, the US formulations segment recorded a 77% increase in revenue to ₹1,003 crore. The company launched three products in the US market during the…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)